Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-31).
about
Early diabetic nephropathy in type 1 diabetes: new insightsPathophysiology of copeptin in kidney disease and hypertensionRenal function is associated with peak exercise capacity in adolescents with type 1 diabetes.The relationship between N-terminal prosomatostatin, all-cause and cardiovascular mortality in patients with type 2 diabetes mellitus (ZODIAC-35).Copeptin testing in acute myocardial infarction: ready for routine use?Diabetes Complications in Childhood Diabetes-New Biomarkers and Technologies.Copeptin and the risk of incident stroke, CHD and cardiovascular mortality in older men with and without diabetes: The British Regional Heart Study.Plasma copeptin levels are inversely associated with intima-media-thickness in men: the population-based KORA F4 study.Urinary Sodium Concentration Is an Independent Predictor of All-Cause and Cardiovascular Mortality in a Type 2 Diabetes Cohort Population.Diabetic Kidney Disease in Adolescents With Type 2 Diabetes: New Insights and Potential Therapies.B-type natriuretic peptide overexpression ameliorates hepatorenal fibrocystic disease in a rat model of polycystic kidney disease.Cross-Sectional Positive Association of Serum Lipids and Blood Pressure With Serum Sodium Within the Normal Reference Range of 135-145 mmol/L.Elevated copeptin is associated with atherosclerosis and diabetic kidney disease in adults with type 1 diabetes.Effects of liraglutide on cardiovascular risk biomarkers in patients with type 2 diabetes and albuminuria: A sub-analysis of a randomized, placebo-controlled, double-blind, crossover trial.Albuminuria is associated with greater copeptin concentrations in men with type 1 diabetes: A brief report from the T1D exchange Biobank.Plasma copeptin as marker of cardiovascular disease in asymptomatic type 2 diabetes patients.
P2860
Q27021632-F411563D-AC48-4F05-A142-4874DE736150Q33792317-178842CB-DC63-4D4F-A18E-51919F51EFBFQ34762311-E7ED5198-AE47-4E78-845A-491D4DA8D716Q35503814-6A2A135D-BE36-42A6-B72E-83E32100E02BQ35556651-92E8D820-4EAB-41C2-B5A9-7FBB16B3BDE6Q36095944-06C7BE27-C466-4C71-B602-E67ED18699B7Q37143797-525DA83E-05C9-4881-8E81-69E62FEB0BE4Q37306950-7240A141-8146-4389-92D8-ACB363DC6E41Q37642298-4A504A09-714F-459F-8329-E9A4D24B03BFQ38709338-9CA24761-FE9A-423A-BE48-09D32CCF119EQ38833791-856B94BF-F025-481B-B4EC-14BE8DE6A223Q39034963-13BD486D-5A51-4529-BB13-18B822953168Q41997691-BD97CEF3-B7AF-4915-8E61-88738E524B26Q48331707-211253DF-462B-48EC-BBCA-758428943983Q50300651-0A6E6001-50E0-4B79-9784-D1887672BC0AQ50648308-9EA37127-B7E0-44C2-BD6F-9F2DB7CD02D8
P2860
Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-31).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Copeptin, a surrogate marker f ...... h type 2 diabetes (ZODIAC-31).
@en
Copeptin, a surrogate marker f ...... h type 2 diabetes (ZODIAC-31).
@nl
type
label
Copeptin, a surrogate marker f ...... h type 2 diabetes (ZODIAC-31).
@en
Copeptin, a surrogate marker f ...... h type 2 diabetes (ZODIAC-31).
@nl
prefLabel
Copeptin, a surrogate marker f ...... h type 2 diabetes (ZODIAC-31).
@en
Copeptin, a surrogate marker f ...... h type 2 diabetes (ZODIAC-31).
@nl
P2093
P2860
P921
P356
P1433
P1476
Copeptin, a surrogate marker f ...... h type 2 diabetes (ZODIAC-31).
@en
P2093
Alaa Alkhalaf
Gerjan Navis
Henk J G Bilo
Ineke J Riphagen
Joachim Struck
Klaas H Groenier
Kornelis J J van Hateren
Nanne Kleefstra
Ron T Gansevoort
Stephan J L Bakker
P2860
P304
P356
10.2337/DC12-2165
P407
P577
2013-06-11T00:00:00Z